325 related articles for article (PubMed ID: 15708075)
21. Therapeutic effect of multiple resiniferatoxin intravesical instillations in patients with refractory detrusor overactivity: a randomized, double-blind, placebo controlled study.
Kuo HC; Liu HT; Yang WC
J Urol; 2006 Aug; 176(2):641-5. PubMed ID: 16813911
[TBL] [Abstract][Full Text] [Related]
22. Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals.
Cruz CD; Charrua A; Vieira E; Valente J; Avelino A; Cruz F
Exp Neurol; 2008 Dec; 214(2):301-8. PubMed ID: 18824169
[TBL] [Abstract][Full Text] [Related]
23. The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.
Liu L; Mansfield KJ; Kristiana I; Vaux KJ; Millard RJ; Burcher E
Neurourol Urodyn; 2007; 26(3):433-8; discussion 439; discussion 451-3. PubMed ID: 17016800
[TBL] [Abstract][Full Text] [Related]
24. Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A.
Smith CP; Vemulakonda VM; Kiss S; Boone TB; Somogyi GT
Neurochem Int; 2005 Sep; 47(4):291-7. PubMed ID: 15970360
[TBL] [Abstract][Full Text] [Related]
25. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury.
Khera M; Somogyi GT; Kiss S; Boone TB; Smith CP
Neurochem Int; 2004 Dec; 45(7):987-93. PubMed ID: 15337297
[TBL] [Abstract][Full Text] [Related]
27. Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells.
Li M; Sun Y; Simard JM; Chai TC
Neurourol Urodyn; 2011 Apr; 30(4):606-11. PubMed ID: 21351130
[TBL] [Abstract][Full Text] [Related]
28. Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin.
Rigoni M; Trevisani M; Gazzieri D; Nadaletto R; Tognetto M; Creminon C; Davis JB; Campi B; Amadesi S; Geppetti P; Harrison S
Br J Pharmacol; 2003 Mar; 138(5):977-85. PubMed ID: 12642400
[TBL] [Abstract][Full Text] [Related]
29. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1.
Birder LA; Nakamura Y; Kiss S; Nealen ML; Barrick S; Kanai AJ; Wang E; Ruiz G; De Groat WC; Apodaca G; Watkins S; Caterina MJ
Nat Neurosci; 2002 Sep; 5(9):856-60. PubMed ID: 12161756
[TBL] [Abstract][Full Text] [Related]
30. Selective pharmacological blockade of the TRPV1 receptor suppresses sensory reflexes of the rodent bladder.
Cefalu JS; Guillon MA; Burbach LR; Zhu QM; Hu DQ; Ho MJ; Ford AP; Nunn PA; Cockayne DA
J Urol; 2009 Aug; 182(2):776-85. PubMed ID: 19539322
[TBL] [Abstract][Full Text] [Related]
31. Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics.
Kuo HC
BJU Int; 2005 May; 95(7):1023-7. PubMed ID: 15839924
[TBL] [Abstract][Full Text] [Related]
32. Bladder sensory desensitization decreases urinary urgency.
Silva C; Silva J; Castro H; Reis F; Dinis P; Avelino A; Cruz F
BMC Urol; 2007 Jun; 7():9. PubMed ID: 17561998
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration.
Datta SN; Roosen A; Pullen A; Popat R; Rosenbaum TP; Elneil S; Dasgupta P; Fowler CJ; Apostolidis A
J Urol; 2010 Dec; 184(6):2578-85. PubMed ID: 21030043
[TBL] [Abstract][Full Text] [Related]
34. Detrusor overactivity induced by intravesical application of adenosine 5'-triphosphate under different delivery conditions in rats.
Nishiguchi J; Hayashi Y; Chancellor MB; de Miguel F; de Groat WC; Kumon H; Yoshimura N
Urology; 2005 Dec; 66(6):1332-7. PubMed ID: 16360479
[TBL] [Abstract][Full Text] [Related]
35. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro.
Shimizu I; Iida T; Horiuchi N; Caterina MJ
J Pharmacol Exp Ther; 2005 Sep; 314(3):1378-85. PubMed ID: 15947039
[TBL] [Abstract][Full Text] [Related]
36. Expression of neuronal nitric oxide synthase (nNOS) and nitric-oxide-induced changes in cGMP in the urothelial layer of the guinea pig bladder.
Gillespie JI; Markerink-van Ittersum M; de Vente J
Cell Tissue Res; 2005 Sep; 321(3):341-51. PubMed ID: 15965654
[TBL] [Abstract][Full Text] [Related]
37. Perineural resiniferatoxin prevents the development of hyperalgesia produced by loose ligation of the sciatic nerve in rats.
Kissin I; Freitas CF; Bradley EL
Anesth Analg; 2007 May; 104(5):1210-6, tables of contents. PubMed ID: 17456676
[TBL] [Abstract][Full Text] [Related]
38. Acid and stretch, but not capsaicin, are effective stimuli for ATP release in the porcine bladder mucosa: Are ASIC and TRPV1 receptors involved?
Sadananda P; Kao FC; Liu L; Mansfield KJ; Burcher E
Eur J Pharmacol; 2012 May; 683(1-3):252-9. PubMed ID: 22421400
[TBL] [Abstract][Full Text] [Related]
39. A high concentration of resiniferatoxin inhibits ion channel function in clonal neuroendocrine cells.
Sugimoto K; Kissin I; Strichartz G
Anesth Analg; 2008 Jul; 107(1):318-24. PubMed ID: 18635503
[TBL] [Abstract][Full Text] [Related]
40. Bradykinin modulates spontaneous nerve growth factor production and stretch-induced ATP release in human urothelium.
Ochodnický P; Michel MB; Butter JJ; Seth J; Panicker JN; Michel MC
Pharmacol Res; 2013 Apr; 70(1):147-54. PubMed ID: 23376352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
